EUVIMEDEUVIMED entdecken
Open Access

Benefit–risk assessment of sonidegib and vismodegib in the treatment of locally advanced basal cell carcinoma

Antonio J García Ruiz, Nuria García-Agua Soler, Enrique Herrera Acosta, Iris Zalaudek, Josep Malvehy

Drugs in Context · 07.07.2022 · 11 · 1-10

DOI: 10.7573/dic.2022-1-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drugs in Context, online erschienen am 07.07.2022. Verfasst von Antonio J García Ruiz und 4 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacology Department, University of Málaga, Institute of Biomedical Research in Malaga (IBIMA), Malaga, Spain. Die Arbeit wurde bisher 13-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

locally advanced basal cell carcinomasonidegibvismodegib

Autor:innen und Institutionen

  • Pharmacology Department, University of Málaga, Institute of Biomedical Research in Malaga (IBIMA), Malaga, Spain.
  • Dermatology Department, Hospital Virgen de la Victoria, Malaga, Spain.
  • Dermatology Department, University of Trieste, Trieste, Italy.
  • Dermatology Department, Hospital Clinic of Barcelona, Institut d'Investigacions Biomediques August Pi I Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
  • Centro de Investigacion Biomedica en Red (CIBER) on Rare Disease, Instituto de Salud Carlos III, Madrid, Spain.

Zitieren

APA

García Ruiz, A. J., García-Agua Soler, N., Herrera Acosta, E., Zalaudek, I., & Malvehy, J. (2022). Benefit–risk assessment of sonidegib and vismodegib in the treatment of locally advanced basal cell carcinoma. Drugs in Context, 11, 1-10. https://doi.org/10.7573/dic.2022-1-2

Vancouver

García Ruiz AJ, García-Agua Soler N, Herrera Acosta E, Zalaudek I, Malvehy J. Benefit–risk assessment of sonidegib and vismodegib in the treatment of locally advanced basal cell carcinoma. Drugs in Context. 2022;11:1-10. doi:10.7573/dic.2022-1-2

BibTeX
@article{GarcaRuiz2022,
  author = {García Ruiz, Antonio J and García-Agua Soler, Nuria and Herrera Acosta, Enrique and Zalaudek, Iris and Malvehy, Josep},
  title = {Benefit–risk assessment of sonidegib and vismodegib in the treatment of locally advanced basal cell carcinoma},
  journal = {Drugs in Context},
  year = {2022},
  volume = {11},
  pages = {1--10},
  doi = {10.7573/dic.2022-1-2}
}
Kostenlos starten →